Federation Des Caisses Desjardins Du Quebec Ionis Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 30, 2024	SELL	$25.61 - $35.1 $5,122 - $7,020	-200 Closed	0 $0
Q3 2021 Aug 30, 2024	BUY	$33.54 - $40.55 $6,708 - $8,109	200 New	200 $6.71 Million
Q4 2020 Aug 30, 2024	BUY	$45.3 - $60.27 $57,576 - $76,603	1,271 New	1,271 $71.9 Million
Q1 2020 Aug 30, 2024	SELL	$41.6 - $63.4 $779,168 - $1.19 Million	-18,730 Closed	0 $0
Q4 2019 Aug 30, 2024	BUY	$53.85 - $65.27 $1.01 Million - $1.22 Million	18,730 New	18,730 $1.13 Billion
Q1 2018 Aug 30, 2024	SELL	$44.08 - $55.05 $1,278 - $1,596	-29 Closed	0 $0
Q3 2017 Aug 30, 2024	SELL	$45.56 - $59.57 $4,556 - $5,957	-100 Reduced 77.52%	29 $1.47 Million
Q2 2017 Aug 30, 2024	BUY	N/A	129	129 $6.56 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account